CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML - Clark,K; Ainscow,E; Peall,A; Thomson,S; Leishman,A; Elaine,S; Ali,S; Coombes,R; Barrett,A; Bahl,AK (AMER SOC HEMATOLOGY, 2017)